Manager Seong Hajun announced that Hanmi Pharmaceutical reached its upper limit, validating the 400,000 won pre-emption price for VIP family members. He also emphasized that nuclear power-related stocks, including BHI, Doosan Enerbility, G2Power, and KEPCO E&C, all experienced significant price surges.
Through these examples, the manager reiterated the importance of a strategy to pre-emptively secure stocks expected to surge. He stressed that accurately reading market trends and responding quickly are key factors in maximizing profits, suggesting that future investment strategies will also focus on pre-emption.
Currently, the nuclear power sector has strong momentum due to increased power demand from AI data centers, which is analyzed to be a factor boosting the long-term growth potential of nuclear power stocks.
Manager Seong Hajun stated, "Yesterday, Hanmi Pharmaceutical once again hit the upper limit, showing quite good trends. As I wrote here, what was the purchase price for VIP family members? 400,000 won. Yes, 400,000 won."